Nobel Prize in Chemistry 2026: Shankar Balasubramanian and David Klenerman (University of Cambridge) for the development of next-generation DNA sequencing (announcement October 7, 2026)
Miss
✦ AI-generated prediction
Published on 1. October 2026
·
Predicted for 7. October 2026
·
Based on: Speculative
The Royal Swedish Academy of Sciences announces the Nobel Prize in Chemistry on October 7. Shankar Balasubramanian and David Klenerman (both University of Cambridge) are the main favorites on small, illiquid prediction markets (Kalshi, Polymarket) for their invention of Sequencing by Synthesis (SBS), the foundation of modern NGS platforms — above all Illumina — which has revolutionized personalized medicine, oncology, and infectious disease epidemiology. Other strongly backed candidates: Pieter Cullis (UBC) for lipid nanoparticle technology (mRNA vaccines) and the skeletal editing trio Sarpong/Levin/Miranda. Kalshi: Balasubramanian/Klenerman as frontrunners without published exact odds; market positioning per Chemistry World and The Scientist implies approximately 20–28% for this duo. Nobel committees historically act surprisingly; probability set at 25%.
Data basis for this prediction
- Kalshi Nobel Chemistry 2026 (kxnobelchem-26): Balasubramanian & Klenerman als Marktfavoriten (Stand 01.10.2026)
- Chemistry World/The Scientist: 'Nobel Prize Chemistry 2026 Predictions' — NGS-Forscher unter Top-3-Picks, Oktober 2026
- ACS Webinar 2026: 'Who Will Win the #ChemNobel?' — Balasubramanian/Klenerman am häufigsten genannt
- RicherNews, Oktober 2026: '2026 Nobel Prize: The Betting Market's Shortlist' — DNA-Sequenzierung im Fokus
Verdict: Miss
Der Chemie-Nobelpreis 2026 wurde am 7. Oktober 2026 tatsächlich bekanntgegeben, jedoch an völlig andere Wissenschaftler: Henri B. Kagan (Frankreich) und Kenso Soai (Japan) erhielten ihn für die 'Entdeckung nichtlinearer Effekte und Autokatalyse in der asymmetrischen organischen Synthese' (chirale Chemie / Spiegelbild-Moleküle). Balasubramanian und Klenerman (Cambridge) für NGS-Sequenzierung gingen leer aus. Quellen: nobelprize.org/prizes/chemistry/2026/press-release/, CNN 07.10.2026, NPR 07.10.2026, SRF Wissen.
💻 Technology
✦ AI
Applied Materials has beaten the EPS consensus in all four of its last reported quarters, with an average earnings surprise of +3.5%. The company's own Q4 guidance is $3.82–$4.22 per share; consensus at $4.06 sits near the midpoint, reflecting classic conservative management framing. Revenue is estimated at $10.30B (+51% YoY) — TSMC and Samsung have not pulled back H2 2026 capex plans. No Polymarket market directly available; a 100% beat streak over 4 quarters with a positive guidance range implies 70–75% probability. Risk: supply chain delays or expanded US export controls on advanced chips could force a Q5 inventory build.
💻 Technology
✦ AI
PLTR closed at $175.40 on November 4, 2026 (after-hours: $170.88, -2.58%; intraday high: $176.54; 52-week high: $212.94). Palantir clearly beat Q3-FY2026 EPS consensus: total revenue $2.313B, US Commercial revenue +148% YoY to $984M. The $185 threshold is +5.5% above the closing price or +8.3% above after-hours levels. Typical post-earnings 'sell the news' may weigh short-term, but the 52-week high of $212.94 confirms the level is reachable. NVIDIA earnings on November 18, 2026 could serve as a sector-wide catalyst. No direct Polymarket equivalent; own estimate: ~42%.
💻 Technology
✦ AI
CBRS trades at $109.18 (October 30, 2026) — already 61% below its all-time high of $279.72. The final and largest lockup expiration is scheduled for November 10, 2026: approximately 19.4 million shares are unlocked (of three tranches of 19.4M each). Prior lockup tranches have consistently weighed on the stock. Insiders have sold ~$394.6M in shares since the May 2026 IPO — zero insider purchases. A Culper Research short-seller report has triggered multiple investigations. A close below $100 requires a ~8.4% decline — plausible given the expected supply pressure on expiration day.